Health in Germany

Welcome to Med-Kolleg - Health in Germany

This Health-Provider-Directory is designed to help doctors and other users to find out information on all aspects of the German health market.
We also refer international travelers requiring medical assistance to qualified doctors or specialists.

Med Kolleg is a health portal with general medicine and health topics. We have search facilities that allows you to find a hospital / clinic or practitioner in Germany from our database (physicians in Germany / hospitals in Germany). Med-Kolleg is completely independent from German insurances, hospitals and doctors.

Please note that general medical information - as provided on this website - does not replace visiting a physician or a medical emergency service, only a physician can assess the individual situation of your health.

Arztsuche

The German Health Care System

The German health care system dates back to 1883, when nationwide health insurance became compulsory. The German health care system has the reputation of being one of the best in the world. Medical facilities are equipped with the latest technology, an extensive network of hospitals and doctors covers even the remotest areas of Germany. Doctors are highly qualified with a thorough education as well as a high level of qualification amongst medical staff.
Read more about the German Health System

Arztverzeichnis

German Health Insurance Schemes

Health insurance in Germany is a part of the social security system.
There are two types of German Health Insurance Schemes - the State Health Insurance and the Private Health Insurance. 88 percent belong to a statutory health scheme and around nine percent are privately insured. Read more...

Health News Germany

2010-09-02:
IBA Sells Prototype of Next Generation Carbon Therapy System
LOUVAIN - LA - NEUVE, Belgium, September 2, 2010 ( PRN/ots ) - IBA ( Ion Beam Applications S.A. ), developer of equipment and pharmaceuticals dedicated to cancer diagnosis and treatment, announced today that it has sold the prototype of its next generation carbon therapy system to the French company (...) Read more...

2010-09-01:
DAIICHI SANKYO Announces Enrollment in the Two Largest Single Phase III Trials so far for the Prevention of Stroke in AF and for the Treatment of VTE is Proceeding as Planned
Stockholm ( PRN/ots ) - DAIICHI SANKYO announced today that the ongoing trials ENGAGE AF - TIMI 48 ( The Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation ) and HOKUSAI VTE with their investigational factor Xa inhibitor edoxaban are enrolling in accordance to plan. The projected recruitment (...) Read more...

2010-09-01:
Largest Atrial Fibrillation Registry Reveals Poor AF Control and High Rates of Cardiovascular Hospitalization
Paris ( PRN/ots ) - Sanofi - aventis announced today that results from the RealiseAF ( Real - life global survey evaluating patients with Atrial Fibrillation ) registry show that control of atrial fibrillation ( AF ) ( defined by the 2006 ACC/AHA/ESC AF guidelines as either sinus rhythm or AF (...) Read more...

2010-08-30:
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Paris, August 30, 2010 ( PRN/ots ) - Sanofi - aventis announced today that the investigational once - daily oral drug teriflunomide significantly reduced annualized relapse rate ( ARR ) at 2 years versus placebo in patients with relapsing multiple sclerosis ( RMS ), thus achieving the primary endpoint in the TEMSO (...) Read more...

2010-08-29:
Multaq( R ) First - line Option in New 2010 ESC Guidelines for the Management of Atrial Fibrillation
Paris, August 29, 2010 ( PRN/ots ) - Sanofi aventis announced today that the European Society of Cardiology ( ESC ) 2010 new Guidelines for the Management of Atrial Fibrillation ( AF ) have been released and recommend that Multaq( R ) ( dronedarone ) should be used for maintenance of sinus rhythm as (...) Read more...

2010-08-17:
Kowa Announces First EU Marketing Authorisation for Pitavastatin Granted in the UK
Wokingham, England, August 17, 2010 ( PRN/ots ) - Kowa are delighted to announce that the Medicines and Healthcare products Regulatory Agency ( MHRA ) has granted a UK licence for their statin, Livazo( R ) ( pitavastatin ). This follows the completion of the decentralized regulatory procedure, in which the MHRA (...) Read more...

2010-08-17:
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials
Indianapolis, August 17, 2010 ( PRN/ots ) - Eli Lilly and Company will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer's disease, because preliminary results from two ongoing long - term Phase III studies showed it did not slow (...) Read more...

2010-08-16:
International Society for Cellular Therapy ( ISCT ) Joins Forces With Roche and Genzyme to Launch Cell Therapy Industry Partnership
Vancouver, August 16, 2010 ( PRN/ots ) - Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the (...) Read more...

2010-08-06:
Avastin Shows Longest Overall Survival for Patients With Adenocarcinoma, the Most Common Type of Advanced Lung Cancer
Basel, Switzerland, August 6, 2010 ( PRN/ots ) - This update outlines data from a preplanned analysis of the pivotal E4599 study in patients with non - small cell lung cancer ( NSCLC ), published in the Journal of Thoracic Oncology. The analysis looked at the impact of treatment (...) Read more...

2010-08-05:
Agendia Inaugurates New State - of - the - Art Genomics Laboratory in Irvine
Irvine, California, and Amsterdam, August 5, 2010 ( PRN/ots ) - Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state - of - the - art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington (...) Read more...

Surveys / Reports

Surveys / Reports

Notifiable Disease Surveillance and Practicing Physicians
Primary care physicians in Germany are essential participants in infectious disease surveillance through mandatory reporting.
In 2001, a new infectious disease control law (IfSG) was implemented in Germany. Most diseases are to be reported to the local county (Landkreis) health department from where they are reported by the state (Land) to the national surveillance institute (Robert Koch Institute). The IfSG also introduced national case definitions for notifiable diseases. The aim of this study was to identify the needs and attitudes of primary care physicians towards public health surveillance.
These issues were investigated in a questionnaire survey among 8,550 randomly sampled physicians in Germany in 2001.
» Krause G, Ropers G, Stark K. Notifiable disease surveillance and practicing physicians. Emerg Infect Dis [serial on the Internet]. 2005 Mar

Latest Entries / Latest Changes

Hospitals: latest entries / changes:

uhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmBH -Universitätsklinik- Lungenzentrum
uhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmBH -Universitätsklinik-
45239 Essen (North Rhine-Westphalia)
(changed: 2010-08-15)
denecke zahnmedizin practiceklinik
denecke zahnmedizin
40721 Hilden (North Rhine-Westphalia)
(changed: 2010-08-15)

3337 entries in clinics directory.

DocSearch: latest entries / changes:

Dr. med. Thorsten Richter
Dr. med. Thorsten Richter
10117 Berlin Mitte (Berlin)
(changed: 2010-08-15)
Peter Matthiesen
Peter Matthiesen
24232 Schönkirchen (Schleswig-Holstein)
(changed: 2010-08-15)

Dentist Search: latest entries / changes:

Nadja Jäger
Nadja Jäger
50733 Köln Nippes (Nordrhein-Westfalen)
(changed: 2010-08-15 )
denecke zahnmedizin
denecke zahnmedizin
40721 Hilden (Nordrhein-Westfalen)
(changed: 2010-08-14 )
   © 2003-2009 med-kolleg.de German Health Care